Achieving Commercial Success with Tissue Engineered Products

The tissue engineering field is finally in a position to capitalize commercially and scale-up to bring tissue engineered products to the masses.

But there are still some huge challenges that need to be overcome before we can turn these innovations into profitable and sustainable businesses. An increasing number of deals are being done in this space, yet there is still no clear commercialization model or exit pathway.

To achieve success, there are several other issues that need to be properly addressed including:

• Making your biotech an attractive investment prospect to raise long-term funding 
• Finding the most effective ways to protect the intellectual property of your innovations 
• Successfully navigating the path from bench to bedside 
• The best methods for effectively marketing a tissue product and understanding your physician target 
• Overcoming the process and manufacturing challenges to scale-up production of your product 
• What are the new licensing strategies following changes in the reimbursement landscape? 
• How do you approach the regulators across the globe to achieve successful filings?

Translational Strategies for Tissue Engineering is the first meeting of its kind designed to bring together business and scientific leaders from tissue engineering companies and translational laboratories to specifically address challenges around commercialization. While companies like Organogenesis and Genzyme Biosurgery already have products in the market, there are a host of others following closely behind that are looking to make their products even more commercially successful.

This global meeting is designed to bring together established and emerging companies, commercially focused laboratories, suppliers of tissue engineering solutions and importantly, investors. You can expect:

• An unparalleled focus on improving commercial viability and driving tissue engineered products through the clinic and to market 
• A rigorous agenda put together by leading tissue engineering business and scientific leaders 
• More networking time built in to two days than any other tissue engineering meeting. 
• Honest, forthright case studies from the most innovative, successful companies in the field